USD 29.8 Billion
Skin Biopsy Market Size, Share, Growth Analysis, By Type (Shave Biopsy, Punch Biopsy, and Excisional Biopsy), By Indication(Skin Cancer Diagnosis and Staging, Actinic Keratosis, and Dermatitis), By End user(Hospitals, and Diagnostic Laboratories), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35D2254 |
Region:
Global |
Published Date: May, 2024
Pages:
219
|Tables:
89
|Figures:
105
Skin Biopsy Market Insights
Global Skin Biopsy Market size was valued at USD 29.8 Billion in 2022 and is poised to grow from USD 31.9 Billion in 2023 to USD 72.46 Billion by 2031, at a CAGR of 10.80% during the forecast period (2024-2031).
The growth of healthcare infrastructure in evolving markets, the occurrence of skin cancer around the world, and a growing demand for advanced healthcare services are projected to drive the skin biopsy market. Skin cancer cases demand skin biopsy procedures, which is a diagnostic tool. For instance, the number of cases of melanoma in the US is increasing which has led to a demand for skin biopsies. Also, a skin biopsy is used for identifying various other skin conditions like dermatitis and psoriasis which contribute to market growth. As the government is investing more in the healthcare industry and the medical tourism sector is growing, the healthcare industry in developing economies leading towards increasing the market. People are looking for less disturbing or invasive medical processes which is raising the demand for biopsies. Biopsies help in identifying cancer and other diseases by observing some tissue samples. These samples are then used by radiologists and diagnostic departments in hospitals and clinics. Different types of cancers are found which could be more than 100 types for which different types of biopsies are available. The growth of the population, disease awareness, unhealthy lifestyles of the people, cancer awareness programs, and spending on healthcare are some of the factors that are influencing the market. Despite that, technological advancements in instruments are also generating opportunities for companies in the skin biopsy market for the upcoming years.
However, there are some challenges faced by the market which include high procedural costs and lack of awareness about the new or advanced procedures in some of the areas which hinder market growth. The market is expected to grow in the future due to new technology and products.
Market Snapshot - (2024-2031)
Global Market Size
Largest Segment
Hospitals
Fastest Growth
Hospitals
Growth Rate
10.80% CAGR
Global Skin Biopsy Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Skin Biopsy Market Segmental Analysis
The global skin biopsy market is segmented based on type, indication, end use and region. By type, the market is segmented into shave biopsy, punch biopsy, and excisional biopsy. By indication, the market is segmented into skin cancer diagnosis and staging, actinic keratosis, and dermatitis. By end use, the market can be segmented into hospitals and diagnostic laboratories. By region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
Analysis By Type
The largest segment is the excisional biopsy segment which accounts for most of the market share. The ability to remove the whole lesions or tumours for the complete analysis of the procedure which ultimately makes it a preferred choice for the for the identification and treatment of various skin conditions which includes skin cancer as well, makes it the largest segment.
On the other hand, the punch biopsy segment is the fastest growing segment in the market. This is led or driven by the less invasive nature, and it can obtain deeper sample of the tissues with minimal damaging, making it increasingly popular among healthcare providers and patients.
Analysis By End user
Hospitals are the largest segment in this market, holding a major share of the market of approximately 40%. The prime providers of healthcare services are the hospitals, including diagnostic processes or treatments like skin biopsies, as they have complete medical facilities and proficiency in patient care. Due to this, the demand for skin biopsy processes in hospitals remains high that leads to the dominancy of this segment. For instance, there are some well-known hospitals such as Mayo Clinic and Johns Hopkins Hospital which are contributing in the majority to this segment.
Meanwhile, the fastest-growing segment in the skin biopsy market is diagnostic laboratories. As the occurrence of skin diseases is growing and the demand for diagnostic services is also increasing, diagnostic laboratories are facing a rise in demand for skin biopsy processes. Some specialized tests and analysis services are offered by diagnostic laboratories, including skin biopsies, to healthcare workers and patients. As technology is advancing it has ultimately risen the market. It supports the diagnostic laboratories to execute accurate and timely biopsy procedures. This has led to the development of the increased growth of this segment. For instance, some centers include LabCorp and Quest Diagnostics are offering complete diagnostic services, including skin biopsies, to healthcare workers and patients.
Global Skin Biopsy Market By End User
To get detailed analysis on other segments, Request For Free Sample Report
Skin Biopsy Market Regional Insights
The dominating region in the global skin biopsy market is North America, which holds a significant market share. North America is expected to lead the global biopsy market from 2024 to 2031 in which United States is playing a huge role. The market share of this region in 2023 was about 40.2% and is expected to keep dominating. The growth in North America is further propelled by many factors including new and improved technology for early stages detection, production of the new kits for earlier diagnosis and increasing demand for less invasive procedures. As cancer cases are rising and government is taking initiatives for early diagnosis is also contributing to the growth of this region. For instance, in June 2023, the National Institute of Government conducted a study on 1308 biopsy proceedings. The study displayed that most of the patients were youths and there were more males than females. Approximately 12.9% of the biopsies were performed on pediatric patients, and most of the patients had only one biopsy. However, there are many people who perform biopsies, primarily for the diagnostic reasons. The patients performing biopsies were mostly 12 years old. Furthermore, the minimally invasive biopsy methods is expected to rise due to its demand among people. The technologies and new products like biopsy guiding systems, needle-based biopsy guns, and vacuum-assisted devices are anticipated to become widespread among the people during the forecasted period. Due to the prevalence of these trends, the market is expected to grow significantly.
Asia Pacific is the fastest growing market in the skin biopsy market and is expected to experience fast growth at a rate of 28.9% from 2024 to 2031. The growth is rising due to awareness of the seriousness of cancer among people. The breast cancer are detected at a high rate in the region which increases the chances of the treatments and the demand for biopsies. The market's growth is also supported by favorable compensation systems. The increase in the widespread of cancer and the authorities are making efforts to raise awareness about cancer screening programs are the main drivers of the market in Asia Pacific. There are many pharmaceutical companies in this region, and countries like China and India can afford such kind of treatments or procedures which is growing market in this region. Furthermore, now-a-days people are learning more about taking care of their skin and getting treated for skin problems, which will make the market bigger in the upcoming times. Additionally, the government has made some great decisions regarding the stricter healthcare guidelines which help in reducing infection risks from invasive biopsy wounds. It is leading to increased market growth. Therefore, skin biopsy is becoming more popular in the area. The development of the skin biopsy market is a key factor driving regional market growth.
Global Skin Biopsy Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Skin Biopsy Market Dynamics
Drivers
Utilizing the Power of Artificial Intelligence
- AI-powered software is helping pathologists by analyzing results of the biopsy procedure in a faster way and more correctly. This technology helps in making the diagnostic process smoother, lowering delays, and making the market more effective. AI is expert in digitizing so adapting the same path here by making it easier to digitize pathology slides and allowing pathologists to refer with experts remotely. This means pathologists can connect online and can share any image online to get opinions from specialists, even in those areas where access to pathology services is very less. This helps connect with specialized expertise easily and drives growth in the global biopsy market.
Government and Institutional Efforts to Raise Public Awareness
- The government and institutions are taking initiatives for increasing awareness about skin cancer and related disorders. For instance, the American Academy of Dermatology is educating people on lowering skin cancer risk and identifying potentially cancerous skin lesions. The AAD also makes clinical practice standards and conducts awareness programs and research in dermatology to improve patient care. Similarly, the Canadian Dermatology Association is also promoting sun protection and skin cancer avoidance.
Restraints
Financial Implications in Biopsy Procedures
- The expenses which are related to biopsy procedures, from assessments before surgery to postoperative care, are considered a major obstacle for market growth. Many people have low or moderate incomes and these procedures cost them a high amount and for healthcare systems also with less budgets. This becomes almost impossible for some people, especially those without good insurance coverage, to afford these biopsy procedures. As a result, creating unequal access to these services, creating healthcare differences. Therefore, people who has limited finances or insufficient insurance may struggle to get biopsies which leads to delays or missed diagnoses. It is important to address these differences to make sure fair healthcare access and support market growth.
Risk of Infection During Biopsy Procedures
- In biopsy procedures, there's a higher risk of infection compared with different choices, which has impelled patient concerns and controlled demand for biopsies in recent times.
Request Free Customization of this report to help us to meet your business objectives.
Skin Biopsy Market Competitive Landscape
In the global skin biopsy market major companies like Integra Lifesciences, Becton, Dickinson and Company, and Innovia Medical are top companies of the market having their advanced biopsy technologies. Additionally, emerging players such as Proscia are presenting innovative AI-powered solutions like DermAI for improved biopsy analysis. This shows that the market is competitive in nature. Overall, there are some dominant players in the market but smaller companies are also competing at the same level and are together contributing to market growth.
Top Player’s Company Profile
- KAI Group
- AccuTec, Inc.
- Becton, Dickinson and Company
- Biomarker Technologies
- Gallini Srl
- Vernacare
- Innovia Medical
- Freenome Holdings, Inc.
- Danaher
- Hologic, Inc.
- Biodesix
- DTR Medical Ltd
- Devicor Medical Products, Inc.
- Leica Biosystems Nussloch GmbH
- Exact Sciences Corporation
- Innovia Medical
- GRAIL, Inc.
- Jai Surgicals Ltd.
- GenMark Diagnostics
- Integra LifeSciences
- Bio-Rad Laboratories
- innoMedicus Ltd
- Genesystems, Inc. (Genesys Biolabs)
- HelioHealth (Laboratory for Advanced Medicine)
- Paramount Surgimed Limited
- World Precision Instruments
- Abbott Laboratories
- Agilent Technologies
- Cardinal Health Inc.
- Guardant Health
- Cook
- Boston Scientific Coorporation
- Biosystems, Inc.
- iSYS Medizintechnik GmbH
- CANON MEDICAL SYSTEMS CORPORATION
- Intuitive Surgical
- Sysmex Corporation
- Olympus
- Lucence Diagnostics Pte. Ltd.
- ANGLE Plc
- Proscia Inc.
- Oncimmune
- Epigenomics AG
- F. Hoffmann-La Roche Ltd.
- Qiagen N.V.
Recent Developments
- In February 2023, SynapsDx introduced a new diagnostic test for Alzheimer's disease based on skin samples. The test uses three biomarkers to detect Alzheimer's and distinguish it from other forms of dementia. It primarily relies on morphometric imaging, which measures cell growth in skin samples from patients. In Alzheimer's patients, there are fewer large aggregates found in the skin cells.
- In May 2023, Argon Medical Devices, Inc. introduced the SuperCore Advantage Semi-Automatic Biopsy instrument, expanding its range of soft tissue biopsy products in the United States.
- In April 2023, GE Healthcare unveiled the bkActiv system designed for surgical applications. This system offers surgeons advanced ultrasound imaging capabilities to enhance visualization during surgical procedures.
- In September 2023, Dxcover Limited expanded its executive team to enhance the development of its multi-cancer liquid biopsy platform and in February 2023, Dxcover Limited secured $11.9 million in Series A funding and grants to progress its liquid biopsy platform for early-stage cancer detection.
Skin Biopsy Key Market Trends
- Increasing Utilization of Integrated Biopsy Methods in Healthcare: In the healthcare industry, there's a growing trend towards combined biopsy techniques to improve diagnostic accuracy and patient outcomes. For acquiring more detailed information from tissue samples, the hospitals like Texas Children's Hospital and United Hospital Central West Virginia are combining different diagnostic processes like image-guided biopsies, endoscopic procedures, and molecular analysis. This technology is helping healthcare workers to understand pathology better, leading to more accurate diagnoses and treatment plans. The integrated biopsy procedures are increasingly adopted by clinicians to improve diagnostic capabilities and patient care. Therefore, there is a predictable rise in the demand for biopsy devices at a faster rate.
Skin Biopsy Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global skin biopsy market analysis, the market is expected to grow due to rise in demand for advanced diagnostic processes for skin disorders. Due to technological advancements and strategies made by key market players, patients are adopting skin biopsy. Also, there is a rise in skin cancer cases around the globe, along with growing awareness about skin biopsy as a diagnostic technique, is helping in the market growth. Additionally, there are many skin conditions or diseases like dermatitis and skin infections whose prevalence is enhancing market expansion. One of the main trend in healthcare is the rising use of integrated biopsy techniques. The government initiatives of promoting awareness in North America and rising awareness about skin health management is expected to see the highest growth due to rising awareness about skin health management and government initiatives promoting awareness. The main companies in the skin biopsy market include Cardinal Health Inc., AccTec Inc., Beckton, Dickenson, and Company, Bio-Rad Laboratories Inc., and Kai Group.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 29.8 Billion |
| Market size value in 2031 | USD 72.46 Billion |
| Growth Rate | 10.80% |
| Base year | 2023 |
| Forecast period | (2024-2031) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Skin Biopsy Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Skin Biopsy Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Skin Biopsy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Skin Biopsy Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Skin Biopsy Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Skin Biopsy Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
